Causes of eating disorders
J Polivy, CP Herman - Annual review of psychology, 2002 - annualreviews.org
▪ Abstract Anorexia nervosa and bulimia nervosa have emerged as the predominant eating
disorders. We review the recent research evidence pertaining to the development of these …
disorders. We review the recent research evidence pertaining to the development of these …
Proline accumulation in plants: a review
N Verbruggen, C Hermans - Amino acids, 2008 - Springer
Proline (Pro) accumulation is a common physiological response in many plants in response
to a wide range of biotic and abiotic stresses. Controversy has surrounded the possible role(…
to a wide range of biotic and abiotic stresses. Controversy has surrounded the possible role(…
How do plants respond to nutrient shortage by biomass allocation?
C Hermans, JP Hammond, PJ White… - Trends in plant …, 2006 - cell.com
Plants constantly sense the changes in their environment; when mineral elements are
scarce, they often allocate a greater proportion of their biomass to the root system. This …
scarce, they often allocate a greater proportion of their biomass to the root system. This …
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
M Slegtenhorst, R Hoogt, C Hermans, M Nellist… - Science, 1997 - science.org
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterized by the
widespread development of distinctive tumors termed hamartomas. TSC-determining loci …
widespread development of distinctive tumors termed hamartomas. TSC-determining loci …
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase …
…, S Marreaud, S Litière, C Hermans, C Fisher… - The lancet …, 2014 - thelancet.com
Background Effective targeted treatment is unavailable for most sarcomas and doxorubicin
and ifosfamide—which have been used to treat soft-tissue sarcoma for more than 30 years—…
and ifosfamide—which have been used to treat soft-tissue sarcoma for more than 30 years—…
Measurements of the NO2 absorption cross-section from 42 000 cm− 1 to 10 000 cm− 1 (238–1000 nm) at 220 K and 294 K
AC Vandaele, C Hermans, PC Simon, M Carleer… - Journal of Quantitative …, 1998 - Elsevier
The NO 2 absorption cross-section has been measured from 42 000 to 10 000 cm −1 (238–1000
nm) with a Fourier transform spectrometer (at the resolution of 2 cm −1 , 0.01 nm at 240 …
nm) with a Fourier transform spectrometer (at the resolution of 2 cm −1 , 0.01 nm at 240 …
Molecular mechanisms of metal hyperaccumulation in plants
N Verbruggen, C Hermans, H Schat - New phytologist, 2009 - Wiley Online Library
… These species diverged c. 5 million yr ago and they show c. 94% nucleotide identity within
… 20 million yr ago and share c. 88% nucleotide identity in coding regions (van de Mortel et al., …
… 20 million yr ago and share c. 88% nucleotide identity in coding regions (van de Mortel et al., …
Mechanisms to cope with arsenic or cadmium excess in plants
N Verbruggen, C Hermans, H Schat - Current opinion in plant biology, 2009 - Elsevier
The metalloid arsenic and the heavy metal cadmium have no demonstrated biological
function in plants. Both elements are highly toxic and of major concern with respect to their …
function in plants. Both elements are highly toxic and of major concern with respect to their …
[HTML][HTML] Gene therapy with etranacogene dezaparvovec for hemophilia B
…, R Kazmi, J Astermark, CRJR Hermans… - … England Journal of …, 2023 - Mass Medical Soc
Background Moderate-to-severe hemophilia B is treated with lifelong, continuous coagulation
factor IX replacement to prevent bleeding. Gene therapy for hemophilia B aims to establish …
factor IX replacement to prevent bleeding. Gene therapy for hemophilia B aims to establish …
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma …
…, MJ Clemons, C Kamby, C Hermans… - European Journal of …, 2001 - Elsevier
CAELYX®/DOXIL®, pegylated liposomal doxorubicin, has shown antitumour activity and
reduced toxicity compared with standard doxorubicin in other tumour types. In this prospective …
reduced toxicity compared with standard doxorubicin in other tumour types. In this prospective …